Blood Clots versus PRF: Activating TGF-β Signaling and Inhibiting Inflammation In Vitro

被引:12
|
作者
Kargarpour, Zahra [1 ]
Panahipour, Layla [1 ]
Miron, Richard J. [2 ]
Gruber, Reinhard [1 ,2 ]
机构
[1] Med Univ Vienna, Univ Clin Dent, Dept Oral Biol, A-1090 Vienna, Austria
[2] Univ Bern, Sch Dent Med, Dept Periodontol, CH-3012 Bern, Switzerland
基金
奥地利科学基金会;
关键词
platelet-rich fibrin; blood clot; inflammation; TGF-beta; toll-like receptors; PLATELET-RICH FIBRIN;
D O I
10.3390/ijms23115897
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The preparation of platelet-rich fibrin (PRF) requires blood centrifugation to separate the yellow plasma from the red erythrocyte fraction. PRF membranes prepared from coagulated yellow plasma are then transferred to the defect sites to support tissue regeneration. During natural wound healing, however, it is the unfractionated blood clot (UBC) that fills the defect site. It is unclear whether centrifugation is necessary to prepare a blood-derived matrix that supports tissue regeneration. The aim of the present study was to compare lysates prepared from PRF and UBC based on bioassays and degradation of the respective membranes. We report here that lysates prepared from PRF and UBC membranes similarly activate TGF-beta signaling, as indicated by the expression of interleukin 11 (IL-11), NADPH oxidase 4 (NOX-4) and proteoglycan 4 (PRG4) in gingival fibroblasts. Consistently, PRF and UBC lysates stimulated the phosphorylation and nuclear translocation of Smad3 in gingival fibroblasts. We further observed that PRF and UBC lysates have comparable anti-inflammatory activity, as shown by the reduction in lipopolysaccharide (LPS)-induced IL-6, inducible nitric oxidase synthase (iNOS) and cyclooxygenase 2 (COX-2) expression in RAW264.7 cells. Moreover, inflammation induced by Poly (1:C) HMW and FSL-1, which are agonists of Toll-like receptor (TLR) 3 and 2/6, respectively, was reduced by both PRF and UBC. PRF and UBC lysates reduced the nuclear translocation of p65 in LPS-induced RAW264.7 cells. In contrast to the similar activity observed in the bioassays, UBC membranes lack the structural integrity of PRF membranes, as indicated by the rapid and spontaneous disintegration of UBC membranes. We show here that the lysates prepared from PRF and UBC possess robust TGF-beta and anti-inflammatory activity. However, visual inspection of the PRF and UBC membranes confirmed the negative impact of erythrocytes on the structural integrity of membranes prepared from whole blood. The data from the present study suggest that although both UBC and PRF have potent TGF-beta and anti-inflammatory activity, UBC does not have the strength properties required to be used clinically to prepare applicable membranes. Thus, centrifugation is necessary to generate durable and clinically applicable blood-derived membranes.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] CBL enhances breast tumor formation by inhibiting tumor suppressive activity of TGF-β signaling
    Kang, J. M.
    Park, S.
    Kim, S. J.
    Hong, H. Y.
    Jeong, J.
    Kim, H-S
    Kim, S-J
    ONCOGENE, 2012, 31 (50) : 5123 - 5131
  • [42] Targeting CEA Rescues Proliferation Inhibiting Effects of TGF-β Signaling Pathway in Colorectal Cancers
    Cao, Hong
    Li, Ying
    Jiao, Zhongxian
    Yao, Wenguo
    Jogunoori, Wilma S.
    Thenappan, Arun
    Mishra, Lopa
    GASTROENTEROLOGY, 2010, 138 (05) : S42 - S42
  • [43] CBL enhances breast tumor formation by inhibiting tumor suppressive activity of TGF-β signaling
    J M Kang
    S Park
    S J Kim
    H Y Hong
    J Jeong
    H-S Kim
    S-J Kim
    Oncogene, 2012, 31 : 5123 - 5131
  • [44] Shenqiwan Ameliorates Renal Fibrosis in Rats by Inhibiting TGF-β1/Smads Signaling Pathway
    Chen, Hongshu
    Xu, Yiqing
    Yang, Yuanxiao
    Zhou, Xiaojie
    Dai, Shijie
    Li, Changyu
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2017, 2017
  • [45] Breviscapine alleviates NASH by inhibiting TGF-β-activated kinase 1-dependent signaling
    Lan, Tian
    Jiang, Shuo
    Zhang, Jing
    Weng, Qiqing
    Yu, Yang
    Li, Haonan
    Tian, Song
    Ding, Xin
    Hu, Sha
    Yang, Yiqi
    Wang, Weixuan
    Wang, Lexun
    Luo, Duosheng
    Xiao, Xue
    Piao, Shenghua
    Zhu, Qing
    Rong, Xianglu
    Guo, Jiao
    HEPATOLOGY, 2022, 76 (01) : 155 - 171
  • [46] Curcumin augments lung maturation, preventing neonatal lung injury by inhibiting TGF-β signaling
    Sakurai, Reiko
    Li, Yishi
    Torday, John S.
    Rehan, Virender K.
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2011, 301 (05) : L721 - L730
  • [47] Silencing DACH1 Promotes Esophageal Cancer Growth by Inhibiting TGF-β Signaling
    Wu, Liang
    Herman, James G.
    Brock, Malcolm V.
    Wu, Kongming
    Mao, Gaoping
    Yan, Wenji
    Nie, Yan
    Liang, Hao
    Zhan, Qimin
    Li, Wen
    Guo, Mingzhou
    PLOS ONE, 2014, 9 (04):
  • [48] Urolithin A attenuates renal fibrosis by inhibiting TGF-β1/Smad and MAPK signaling pathways
    Cheng, Zhenzhen
    Tu, Jingjing
    Zhang, Hongpan
    Zhang, Yi
    Zhou, Benhong
    JOURNAL OF FUNCTIONAL FOODS, 2021, 83
  • [49] Inhibiting TGF-β signaling restores immune surveillance in the SMA-560 glioma model
    Tran, Thomas-Toan
    Uhl, Martin
    Ma, Jing Ying
    Janssen, Lisa
    Sriram, Venkataraman
    Aulwurm, Steffen
    Kerr, Irene
    Lam, Andrew
    Webb, Heather K.
    Kapoun, Ann M.
    Kizer, Darin E.
    McEnroe, Glenn
    Hart, Barry
    Axon, Jonathan
    Murphy, Alison
    Chakravarty, Sarvajit
    Dugar, Sundeep
    Protter, Andrew A.
    Higgins, Linda S.
    Wick, Wolfgang
    Weller, Michael
    Wong, Darren H.
    NEURO-ONCOLOGY, 2007, 9 (03) : 259 - 270
  • [50] Tyrosine kinase receptor B attenuates liver fibrosis by inhibiting TGF-β/SMAD signaling
    Song, Yu
    Wei, Jiayi
    Li, Rong
    Fu, Ruifeng
    Han, Pei
    Wang, Heming
    Zhang, Guangcong
    Li, Shuyu
    Chen, Sinuo
    Liu, Zhiyong
    Zhao, Yicheng
    Zhu, Changfeng
    Zhu, Jimin
    Zhang, Shuncai
    Pei, Hao
    Cheng, Jiefei
    Wu, Jian
    Dong, Ling
    Song, Guangqi
    Shen, Xizhong
    Yao, Qunyan
    HEPATOLOGY, 2023, 78 (05) : 1433 - 1447